Shellac-based composite nanodelivery system, its preparation method and application
By combining shellac, unsaturated fatty acids, and proteins, and utilizing pH cycle-driven antisolvent precipitation self-assembly technology, a surfactant-free shellac-based composite nanodelivery system was prepared. This solved the problem of insufficient chemical stability in existing technologies and achieved efficient astaxanthin encapsulation and long-term storage stability.
Patent Information
- Application Number
- CN202611538186.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-30
- Publication Date
- 2026-11-17
AI Technical Summary
Existing shellac-based nanodelivery systems generally rely on synthetic surfactants to improve particle size and encapsulation efficiency, which leads to a decrease in the chemical stability of the active material. There is an urgent need to provide a surfactant-free shellac-based composite nanodelivery system.
Shellac, unsaturated fatty acids, and proteins were used as astaxanthin carrier components. A composite nanodelivery system was formed through pH cycle-driven antisolvent precipitation self-assembly technology, avoiding the use of surfactants.
It achieved good encapsulation and loading of astaxanthin and other loading substances, improving long-term storage stability, with an encapsulation rate of 70.85% and a storage half-life of 186 days.
Smart Images

Figure CN123100838A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of nanodelivery systems technology, specifically to a shellac-based composite nanodelivery system, its preparation method, and its applications. Background Technology
[0002] Astaxanthin is a high-value ketocarotenoid with extremely strong antioxidant activity. Its ability to quench singlet oxygen is approximately 550 times that of vitamin E, and its antioxidant capacity is 10 to 500 times that of β-carotene. However, astaxanthin has extremely low water solubility and contains multiple conjugated unsaturated double bonds, making it highly sensitive to light, heat, and oxygen. It is easily degraded and inactivated during processing and storage, and its oral bioavailability is typically less than 10%, which severely limits its application in food, health products, and aquatic feed.
[0003] Constructing nanodelivery systems using natural polymers such as shellac is an effective way to overcome the above problems. Shellac, a natural resin secreted by lac insects, has been recognized as a safe substance by the U.S. Food and Drug Administration. It possesses amphiphilic properties and unique pH-responsive characteristics (pKa approximately 6.9-7.5), remaining stable in the acidic gastric environment and soluble in the neutral intestinal environment, making it an ideal material for constructing targeted delivery carriers. Food-grade proteins such as sodium caseinate are amphiphilic and can act as emulsifiers and stabilizers. Chinese patent document CN121154581A discloses a method for preparing shellac-sodium caseinate composite nanoparticles loaded with oregano essential oil. This method uses an antisolvent precipitation method to assemble shellac and sodium caseinate, and uses Tween80 as a nonionic surfactant to improve particle dispersibility. Although this method achieves the encapsulation of hydrophobic active substances, the introduction of surfactants still leads to a decrease in the chemical stability of the active substances.
[0004] In summary, existing shellac-based nanodelivery systems generally rely on synthetic surfactants to improve particle size and encapsulation efficiency. However, surfactants can significantly weaken the long-term chemical stability of active substances. Therefore, there is an urgent need to provide a shellac-based composite nanodelivery system that can achieve high chemical stability without the use of surfactants. Summary of the Invention
[0005] The technical problem to be solved by the present invention is to overcome the shortcomings of the prior art and provide a shellac-based composite nanodelivery system under surfactant-free conditions, its preparation method and application, which uses shellac, unsaturated fatty acids and proteins as astaxanthin carrier components, without the need for surfactants, to achieve good encapsulation and loading of astaxanthin and other loaded materials.
[0006] The technical solution of this invention is as follows: In a first aspect, a shellac-based composite nanodelivery system is disclosed, comprising a carrier and a loading material, wherein the carrier is formed by self-assembly of shellac SL, unsaturated fatty acids and proteins through pH cycle-driven coupled antisolvent precipitation, and the delivery system does not contain a surfactant.
[0007] Preferably, the protein is one of sodium caseinate, whey protein, soy protein isolate, and zein.
[0008] Preferably, the loading material is at least one of astaxanthin, β-carotene, lycopene, curcumin, coenzyme Q10 and vitamin D3.
[0009] Preferably, the unsaturated fatty acid is at least one of oleic acid, linoleic acid, and α-linolenic acid.
[0010] Preferably, the mass ratio of the shellac, unsaturated fatty acids, and protein is 1:4:2.
[0011] Secondly, a method for preparing the aforementioned shellac-based composite nanodelivery system is disclosed, comprising the following steps: 1) Preparation of alkaline shellac solution: Dissolve shellac in an alkaline aqueous solution to obtain alkaline shellac solution; 2) Preparation of protein solution: Dissolve the protein in water or an alkaline aqueous solution to obtain a protein solution; 3) Preparation of fatty acid solution: Dissolve unsaturated fatty acids in organic solvent one to obtain fatty acid solution; 4) Preparation of the loaded solution: The loaded substance was dissolved in organic solvent II to obtain the loaded organic solution; 5) Preparation of shellac-based composite nanodelivery system: The protein solution in step 2) is added to the alkaline shellac solution in step 1), the pH is adjusted to 10-12, and the mixture is mixed evenly. Then, the fatty acid solution in step 3) is added, stirred and allowed to stand. The organic loading solution prepared in step 4) is added to the mixture, the pH of the system is adjusted to neutral or weakly acidic, self-assembly is triggered, centrifuged, the organic solvent is removed, and the mixture is lyophilized to obtain the shellac-based composite nanodelivery system.
[0012] Preferably, in step 1), the alkaline aqueous solution is a sodium hydroxide solution, and the concentration of shellac in the shellac alkaline solution is 15-25 mg / mL; in step 2), when the protein is dissolved in the alkaline aqueous solution, the alkaline aqueous solution is a sodium hydroxide solution, and the concentration of the protein solution is 4-6 mg / mL; in step 3), the first organic solvent is ethanol, and the concentration of the fatty acid solution is 25-35 mmol / L; in step 4), the second organic solvent is a mixture of dichloromethane and ethanol, and the volume ratio of dichloromethane to ethanol is 1:1.
[0013] Preferably, hydrochloric acid is used to adjust the pH to 10-12 in step 5); if the neutral or weakly acidic pH value is 4-7, hydrochloric acid is used to adjust the pH to 4-7.
[0014] Preferably, the stirring time in step 5) is 3-10 min, and the standing time is 3-10 min.
[0015] Thirdly, the application of the described shellac-based composite nanodelivery system in the preparation of food, health products, or aquatic feed additives is disclosed.
[0016] Shellac's pH-responsive characteristics facilitate the formation of hydrophobic complex structures during pH changes; sodium caseinate possesses amphiphilic and interfacial stabilizing capabilities, improving the aqueous dispersion of the shellac-based system; and the long-chain hydrophobic structure of oleic acid participates in the hydrophobic association between shellac and astaxanthin, thereby regulating the hydrophobic microenvironment within the carrier. The combined action of these three carrier components enables effective encapsulation and loading of astaxanthin without the addition of surfactants such as Tween 80, achieving good long-term storage stability.
[0017] The SL-OA-NaCas-AST composite delivery system is primarily formed through pH cycling coupled with antisolvent precipitation and multiple non-covalent interactions. Under alkaline conditions, the carboxyl groups of shellac are deprotonated and fully dispersed; sodium caseinate is mixed with shellac to form a homogeneous aqueous system. Subsequently, an oleic acid ethanol solution and an astaxanthin organic solution are added. As oleic acid and astaxanthin enter the aqueous continuous phase from the organic phase, their solvent environment undergoes abrupt changes, resulting in an antisolvent precipitation / solvent displacement effect, and they associate with shellac and sodium caseinate through hydrophobic interactions. Further lowering the pH of the system from alkaline to neutral decreases the ionization of shellac and enhances hydrophobic interactions, thereby promoting further composite assembly of the components; sodium caseinate, with its amphiphilic properties, plays an interfacial stabilizing role. Finally, rotary evaporation removes the organic solvent, further stabilizing the composite structure and forming the SL-OA-NaCas-AST composite delivery system.
[0018] Compared with the prior art, the present invention has the following advantages: 1. The shellac-based composite nanodelivery system prepared by the present invention uses shellac, unsaturated fatty acids and proteins as astaxanthin carrier components, without the need for surfactants, to achieve good encapsulation and loading of astaxanthin and other loads.
[0019] 2. The shellac-based composite nanodelivery system prepared by this invention has an astaxanthin encapsulation rate of 70.85%, a loading of 5.03%, and a fitted storage half-life of 186 days under light-protected conditions at 4℃. This invention maintains good astaxanthin loading performance without the addition of Tween 80 and improves long-term low-temperature storage stability. Attached Figure Description
[0020] Figure 1 This is a flowchart of the preparation process for Example 1.
[0021] Figure 2 DLS particle size distribution of the shellac-based composite nanodelivery system SL-OA-NaCas-AST prepared in Example 1.
[0022] Figure 3 Transmission electron microscope (TEM) image (A) and transmission electron microscope statistical particle size distribution (TEM) image (B) of the SL-LA-AST composite particles prepared for Comparative Example 4.
[0023] Figure 4 This is a transmission electron microscope image of SL-NaCas-AST particles prepared in Comparative Example 5 of this invention.
[0024] Figure 5 The image shows a superimposed comparison of the infrared spectra of the nanoparticles, SL-NaCas, and reaction raw materials formed in Comparative Example 5.
[0025] Figure 6 The images show the XRD patterns of the nanoparticles, SL-NaCas, and reaction materials formed in Comparative Example 5.
[0026] Figure 7 The degradation curves of astaxanthin in Comparative Examples 5 and 6 and Tween80-AST under different storage conditions are shown. (A) 20℃, natural light irradiation; (B) 20℃, protected from light; (C) 4℃, protected from light.
[0027] Figure 8 Particle size / PDI variation and Zeta potential (B) of SL-NaCas-AST and SL-NaCas-Tween80-AST in Comparative Examples 5 and 6 under different pH (A), salt concentration (D), and heating time (C).
[0028] Figure 9 The effects of different fatty acid types and FA / SL mass ratios on the formation properties of FA-SL composite particles. (A) Average particle size; (B) PDI. Detailed Implementation
[0029] To enable those skilled in the art to better understand the technical solutions of this invention, the technical solutions of this invention will be clearly and completely described below in conjunction with the embodiments of this invention.
[0030] Example 1 The fabrication process of the shellac-based composite nanodelivery system is shown in the flowchart below. Figure 1 As shown, it includes the following steps: 1) Preparation of alkaline shellac solution: Dissolve shellac SL in 0.1 mol / L NaOH solution and stir magnetically at 500 r / min for 12 h to prepare a 20 mg / mL alkaline shellac solution; 2) Preparation of protein solution: Sodium caseinate was dissolved in ultrapure water to obtain a 5 mg / mL protein solution; 3) Preparation of fatty acid solution: Oleic acid was dissolved in anhydrous ethanol to obtain an ethanol solution of 30 mmol / L oleic acid; 4) Preparation of loading solution: Astaxanthin was dissolved in a solvent with a volume ratio of dichloromethane to ethanol of 1:1 to obtain a 0.5 mg / mL loading organic solution; 5) Preparation of the shellac-based composite nanodelivery system: Add 8.89 mL of the protein solution from step 2) to 1.11 mL of the alkaline shellac solution from step 1), adjust the pH to 11 with 1 mol / L HCl, mix well, then add 10.48 mL of the ethanol solution of oleic acid from step 3), so that the mass ratio of oleic acid to shellac is 4:1, stir for 5 min, and let stand for 5 min; then add 20.48 mL of the loading organic solution prepared in step 4), so that the final concentration of astaxanthin in the system reaches 0.25 mg / mL, adjust the pH of the system to 7.0 with 1 mol / L HCl, trigger the self-assembly of the shellac-oleic acid-sodium caseinate complex and encapsulate astaxanthin, centrifuge (4000 g, 10 min), take the supernatant, remove the organic solvent by rotary evaporation, and obtain a uniform shellac-based composite nanodelivery system SL-OA-NaCas-AST aqueous dispersion, freeze-dry to obtain the shellac-based composite nanodelivery system.
[0031] The encapsulation efficiency, loading capacity, and stability of astaxanthin during storage at 4℃ in the dark were determined. The results showed that the encapsulation efficiency of the SL-OA-NaCas-AST system was 70.85%, the loading capacity was 5.03%, and the storage half-life of astaxanthin under first-order kinetics at 4℃ in the dark was 186 days.
[0032] The DLS particle size distribution of the shellac-based composite nanodelivery system SL-OA-NaCas-AST is shown in the figure below. Figure 2 As shown in the figure, the average particle size is 185 nm.
[0033] Example 2 Unlike Example 1, this example replaces the fatty acid solution with 10.55 mL of 30 mmol / L linoleic acid in ethanol. The rest of the preparation methods and steps are the same as in Example 1. The encapsulation efficiency of the composite nanodelivery system is 65.7%, and the loading is 4.16%.
[0034] Comparative Example 1 Unlike Example 1, in this comparative example, the fatty acid solution was replaced with a 30 mmol / L stearic acid ethanol solution, specifically: 1) Dissolve shellac in 0.1 mol / L NaOH solution and stir magnetically at 500 r / min for 12 h to prepare a 20 mg / mL alkaline shellac solution; Steps 2) and 4) are the same as in Example 1. In step 3), a 30 mmol / L ethanol solution of stearic acid is prepared.
[0035] 5) Add 8.89 mL of the protein solution from step 2) to 1.11 mL of the shellac alkaline solution from step 1), adjust the pH to 11 with 1 mol / L HCl, mix well, then add 10.4 mL of the stearic acid ethanol solution from step 3), stir for 5 min, and let stand for 5 min; obvious precipitation occurs, making it impossible to carry out subsequent astaxanthin loading.
[0036] Comparative Example 2 Unlike Example 1, in this comparative example, the fatty acid (oleic acid) solution was replaced with an ethanol solution of 30 mmol / L lauric acid, specifically: 1) Dissolve shellac in 0.1 mol / L NaOH solution and stir magnetically at 500 r / min for 12 h to prepare a 20 mg / mL alkaline shellac solution; Steps 2) and 4) are the same as in Example 1. In step 3), a 30 mmol / L ethanol solution of lauric acid is prepared.
[0037] 5) Add 8.89 mL of the protein solution from step 2) to 1.11 mL of the shellac alkaline solution from step 1), adjust the pH to 11 with 1 mol / L HCl, mix well, then add 14.78 mL of the lauric acid ethanol solution from step 3), stir for 5 min, and let stand for 5 min; then add 24.78 mL of the loading organic solution prepared in step 4) to make the final concentration of astaxanthin in the system reach 0.25 mg / mL, adjust the pH of the system to 7.0 with 1 mol / L HCl, a large amount of flocculent precipitate is produced, and self-assembly cannot be successfully carried out, that is, the delivery system cannot be obtained.
[0038] Comparative Example 3 Unlike Example 1, in step 5) of this comparative example, the amount of oleic acid ethanol solution added in step 3) was changed, so that the mass ratio of oleic acid to shellac was 6:1, and the volume of the loading solution added was 23.1 mL, in order to maintain the final concentration of the loading solution at 0.25 mg / mL. The remaining preparation methods and steps were the same as in Example 1. The final delivery system had an uneven particle size distribution, and the PDI value was larger than that of Example 1.
[0039] Comparative Example 4 Unlike Example 2, this comparative example does not include a protein solution. Instead, shellac and linoleic acid are used as carriers to prepare the SL-LA-AST delivery system, specifically: 1) Preparation of alkaline shellac solution: Dissolve shellac in 0.1 mol / L NaOH solution and stir magnetically at 600 r / min for 12 h to prepare a 20 mg / mL alkaline shellac solution; 2) Preparation of fatty acid solution: Linoleic acid was dissolved in anhydrous ethanol to obtain an ethanol solution of 30 mmol / L linoleic acid; 3) Preparation of the loaded solution: Astaxanthin was dissolved in DMSO to obtain an organic solution of the loaded substance at a concentration of 0.6 mg / mL; 4) Preparation of the shellac-based composite nanodelivery system: 1.11 mL of the alkaline shellac solution from step 1) was adjusted to pH 11 with 1 mol / L HCl and mixed thoroughly. Linoleic acid ethanol solution was added to the alkaline shellac solution at a linoleic acid to shellac mass ratio of 4:1. The mixture was stirred for 5 min and allowed to stand for 5 min. Then, the astaxanthin solution obtained in step 3) was added to bring the final astaxanthin concentration in the system to 0.12 mg / mL. The mixture was vortexed for 5 min and allowed to stand for 5 min. The pH of the system was then adjusted to 7.0 with 1 mol / L HCl. The system was centrifuged at 4000g for 10 min, and the supernatant was collected to obtain an aqueous dispersion of the SL-LA-AST delivery system. After lyophilization, the shellac-based composite nanodelivery system was obtained. TEM images and statistical particle size distributions of the SL-LA-AST composite particles are shown below. Figure 3 As shown. The encapsulation efficiency was measured to be 65.12% and the loading was 1.77%. Compared with Example 2 (SL-LA-NaCas-AST, encapsulation efficiency 65.7%, loading 4.16%), the encapsulation efficiency of the two is similar, but the loading of the protein-free SL-LA-AST system is lower.
[0040] Comparative Example 5 Unlike Example 1, this comparative example does not include a fatty acid solution; specifically: 1) Preparation of alkaline shellac solution: Dissolve shellac in 0.1 mol / L NaOH solution and stir magnetically at 500 r / min for 12 h to prepare a 20 mg / mL alkaline shellac solution; 2) Preparation of protein solution: Sodium caseinate was dissolved in ultrapure water to obtain a 5 mg / mL protein solution; 3) Preparation of loading solution: Astaxanthin was dissolved in a solvent with a volume ratio of dichloromethane to ethanol of 1:1 to obtain a 0.5 mg / mL loading organic solution; 4) Preparation of the shellac-based composite nanodelivery system: 8.89 mL of the protein solution from step 2) was added to 1.11 mL of the alkaline shellac solution from step 1). The pH was adjusted to 11 with 1 mol / L HCl, mixed thoroughly, stirred for 5 min, and allowed to stand for 5 min. Then, 10 mL of the organic loading solution prepared in step 3) was added to bring the final astaxanthin concentration in the system to 0.25 mg / mL. The pH was adjusted to 7.0 with 1 mol / L HCl to trigger the self-assembly of the shellac-sodium caseinate complex and encapsulation of astaxanthin. The mixture was centrifuged (4000 g, 10 min), and the supernatant was collected. The organic solvent was removed by rotary evaporation to obtain a homogeneous aqueous dispersion of the shellac-based composite nanodelivery system SL-NaCas-AST. After lyophilization, the shellac-based composite nanodelivery system SL-NaCas-AST was obtained. The encapsulation efficiency of SL-NaCas-AST was 54.70%, and the loading was 3.94%.
[0041] Transmission electron microscope image of SL-NaCas-AST particles as shown below Figure 4 As shown, the SL-NaCas-AST particles are approximately spherical in shape, with a TEM statistical particle size of 18.03 ± 3.16 nm. It should be noted that TEM reflects the particle size in a dry state, and is not equivalent to the hydration kinetic size measured by DLS.
[0042] Infrared spectroscopy was performed on the raw materials sodium caseinate, shellac, astaxanthin, SL-NaCas, and SL-NaCas-AST particles, and the results are as follows: Figure 5 As shown in the figure. The preparation method of SL-NaCas nanoparticles is as follows: SL is dissolved in 0.1 mol / L NaOH solution to prepare a 20 mg / mL SL solution, and the solution is magnetically stirred at 500 r / min for 12 h at a constant temperature. NaCas is dissolved in ultrapure water, and the pH of the solution is adjusted to 12 to prepare a 5 mg / mL NaCas solution, which is then magnetically stirred at 500 r / min for 12 h at a constant temperature. NaCas solution is added to the SL solution to make the SL-NaCas mass ratio 1:2. The pH of the solution is adjusted to 11 with 1 mol / L HCl, and the mixture is magnetically stirred at 500 r / min for 5 min. The pH of the solution is then adjusted to 7 with 1 mol / L HCl. Finally, the mixture is centrifuged at 4000g for 10 min, and the supernatant is collected to obtain the SL-NaCas nanoparticle solution.
[0043] FTIR results showed that, compared with other raw materials, the AST in SL-NaCas-AST was at 1652.38 cm⁻¹. -1 and 1528.08 cm -1 The characteristic absorption peak in the vicinity is significantly weakened, at 976.94 cm⁻¹. -1The disappearance of nearby characteristic absorption peaks, along with changes in NaCas-related absorption peaks, indicates a strong intermolecular interaction between AST and the SL-NaCas support, with AST effectively encapsulated within the composite support.
[0044] XRD tests were performed on the raw materials sodium caseinate, shellac, astaxanthin, SL-NaCas, and SL-NaCas-AST particles, and the results are as follows: Figure 6 As shown.
[0045] XRD results showed that pure AST had obvious crystal diffraction peaks, while the corresponding AST crystal characteristic peaks in SL-NaCas-AST were significantly weakened or absent, indicating that the crystallization state of AST changed significantly after entering the SL-NaCas support.
[0046] Comparative Example 6 Unlike Comparative Example 5, in this comparative example, step 4) involves adding 8.89 mL of the protein solution from step 2) to 1.11 mL of the shellac alkaline solution from step 1), adjusting the pH to 11 with 1 mol / L HCl, mixing thoroughly, stirring for 5 min, and letting stand for 5 min; then adding 7% (v / v) Tween80; adding 10 mL of the loading organic solution prepared in step 3), and adjusting the pH of the system to 7 with 1 mol / L HCl to trigger self-assembly and encapsulate astaxanthin; centrifuging (4000 g, 10 min), collecting the supernatant, removing the organic solvent by rotary evaporation (40 °C) to obtain an aqueous dispersion of the delivery system, and lyophilizing to obtain SL-NaCas-Tween80-AST. The astaxanthin encapsulation efficiency of SL-NaCas-Tween80-AST was determined to be 77.59%, slightly higher than that of Example 1 (70.85%). However, its astaxanthin storage half-life, obtained by fitting first-order degradation kinetics at 4°C in the dark, was only 63 days, approximately one-third of that of Example 1 (186 days). Encapsulation efficiency primarily reflects the astaxanthin loading capacity of the delivery system upon completion of preparation, while storage half-life further reflects the stability and protection of astaxanthin during long-term storage. These results indicate that while Tween80 can improve initial encapsulation performance, it impairs long-term storage stability. In contrast, the SL-OA-NaCas-AST composite delivery system described in Example 1, without the addition of Tween 80, maintained a high astaxanthin encapsulation efficiency and loading capacity, while also achieving a longer storage half-life at 4°C in the dark. This suggests that the synergistic introduction of oleic acid and sodium caseinate can achieve a better balance between astaxanthin loading performance and long-term storage stability.
[0047] The degradation curves of astaxanthin in Comparative Examples 5 and 6, and Tween80-AST under different storage conditions are shown in the figure. Figure 7As shown. The preparation method of Tween80-AST is as follows: 7% (v / v) Tween80 is added to 10 mL of alkaline aqueous solution with pH=11; 10 mL of the loading organic solution prepared in step 4) of Example 1 is added to it, and the pH of the system is adjusted to 7 with 1 mol / L HCl to trigger self-assembly and encapsulate astaxanthin. After centrifugation (4000g, 10 min), the supernatant is taken and the organic solvent is removed by rotary evaporation (40℃) to obtain the aqueous dispersion of the delivery system. The specific test method of degradation curve: The three nanoparticle solutions of SL-NaCas-Tween80-AST, SL-NaCas-AST and Tween80-AST are respectively placed in (1) 20℃, natural light; (2) 20℃, protected from light; (3) 4℃, protected from light. The residual AST concentration in the sample is measured every 5 days, and the measurement is continuously measured for 20 days. The results are fitted according to the first-order degradation kinetics: ln(C / C0)=-kt; according to t 1 / 2 =ln2 / k calculates the fitted storage half-life.
[0048] The particle size / PDI changes of SL-NaCas-AST and SL-NaCas-Tween80-AST in Comparative Examples 5 and 6 under different pH, salt concentrations and heating times were tested. The specific test methods were as follows: (1) pH stability. The lyophilized and reconstituted nanoparticle solutions were divided into equal portions, and their pH was adjusted to 2.0, 3.0, 4.0, 5.0, 6.0, 7.0 and 8.0 respectively with 1 mol / L HCl or 1 mol / L NaOH. After standing at 4℃ for 8 h, the particle size of each group was measured by a dynamic light scattering particle size analyzer. Zeta Potential. (2) Salt stability. A 5 mol / L NaCl solution was added to the reconstituted nanoparticle solution, so that the NaCl solution concentration in each sample was 0, 0.1, 0.2, 0.5, 1, 1.5, and 2 mol / L, respectively. After the samples were stored at 4℃ for 8 h, the particle size of the nanoparticles was determined using a dynamic light scattering particle size analyzer. Zeta Potential. (3) Thermal stability. The reconstituted nanoparticle solution was heated in an 80℃ constant temperature water bath for 3 hours, with samples taken every 30 minutes. After standing at 4℃ for 8 hours, the particle size of each group was determined by a dynamic light scattering particle size analyzer. Zeta Potential. Test results are as follows: Figure 8 As shown.
[0049] It should be noted that the astaxanthin encapsulation efficiency EE (%) and LC (%) were determined as follows: 0.3 mL of the aqueous dispersion of the composite delivery system was taken, 0.7 mL of ultrapure water was mixed with 6 mL of dichloromethane / methanol mixture (2:1, v / v) and vortexed thoroughly for 10 min. Then, the mixture was centrifuged at 8000 rpm for 10 min, the dichloromethane organic phase was collected, and the astaxanthin content was determined using the astaxanthin standard curve.
[0050] The calculation formula is: EE (%) = Mass of AST packaged in the composite delivery system / Total mass of AST input × 100%.
[0051] LC (%) = Mass of AST encapsulated in the composite delivery system / Total mass of dry matter in the composite particles × 100%.
[0052] The specific test standard method for the half-life at 4℃ in the dark is as follows: Store the sample at 4℃ in the dark, measure the remaining AST concentration in the sample every 5 days, and continue the measurement for 20 days. Fit the half-life according to the first-order degradation kinetics: ln(C / C0)=-kt; calculate the fitted storage half-life according to t1 / 2=ln2 / k.
[0053] To investigate the effect of fatty acid type on nanodelivery systems, shellac SL was dissolved in 0.1 mol / L NaOH aqueous solution and magnetically stirred at 500 r / min for 12 h to prepare SL solutions of the same concentration. After adjusting the pH of the system to 11.0 with HCl, ethanol solutions of lauric acid (LAA), oleic acid (OA), and linoleic acid (LA) were added to form composites.
[0054] The experimental results show that LAA-SL, OA-SL, and LA-SL all exhibit good dispersion during the preparation of FA-SL particles. When further loaded with AST, the SL-LAA-AST system has a larger particle size and PDI and becomes flocculent after dilution, while OA-SL-AST and LA-SL-AST have smaller particle size and better dispersion. Therefore, OA and LA were selected for further research.
[0055] Systems with FA / SL mass ratios of 1:1, 2:1, 4:1, and 6:1 were screened. The particle size and PDI results of the prepared delivery systems are as follows: Figure 9 As shown in the figure, FA represents fatty acids. When the mass ratio of FA:SL is 4:1, the particle size is small and the particle size distribution is relatively uniform. After further increasing FA to 6:1, the particle size improvement is not obvious, and the PDI of some systems actually increases. Therefore, FA:SL=4:1 is selected as the optimal experimental condition.
Claims
1. A shellac-based composite nanodelivery system, characterized in that, The system includes a carrier and a loading material, wherein the carrier is formed by the self-assembly of shellac, unsaturated fatty acids and proteins through pH cycle-driven coupled antisolvent precipitation, and the delivery system does not contain a surfactant.
2. The shellac-based composite nanodelivery system as described in claim 1, characterized in that, The protein is one of sodium caseinate, whey protein, soy protein isolate, and zein.
3. The shellac-based composite nanodelivery system as described in claim 1, characterized in that, The loading material is at least one of astaxanthin, β-carotene, lycopene, curcumin, coenzyme Q10, and vitamin D3.
4. The shellac-based composite nanodelivery system as described in claim 1, characterized in that, The unsaturated fatty acid is at least one of oleic acid, linoleic acid, and α-linolenic acid.
5. The shellac-based composite nanodelivery system as described in claim 1, characterized in that, The mass ratio of the shellac, unsaturated fatty acids, and protein components is 1:4:
2.
6. The method for preparing the shellac-based composite nanodelivery system according to any one of claims 1-5, characterized in that, Includes the following steps: 1) Preparation of alkaline shellac solution: Dissolve shellac in an alkaline aqueous solution to obtain alkaline shellac solution; 2) Preparation of protein solution: Dissolve the protein in water or an alkaline aqueous solution to obtain a protein solution; 3) Preparation of fatty acid solution: Dissolve unsaturated fatty acids in organic solvent one to obtain fatty acid solution; 4) Preparation of the loaded solution: The loaded substance was dissolved in organic solvent II to obtain the loaded organic solution; 5) Preparation of shellac-based composite nanodelivery system: The protein solution in step 2) is added to the alkaline shellac solution in step 1), the pH is adjusted to 10-12, and the mixture is mixed evenly. Then, the fatty acid solution in step 3) is added, stirred and allowed to stand. The organic loading solution prepared in step 4) is added to the mixture, the pH of the system is adjusted to neutral or weakly acidic, self-assembly is triggered, centrifuged, the organic solvent is removed, and the mixture is lyophilized to obtain the shellac-based composite nanodelivery system.
7. The method for preparing the shellac-based composite nanodelivery system as described in claim 6, characterized in that, In step 1), the alkaline aqueous solution is a sodium hydroxide solution, and the shellac concentration in the alkaline shellac solution is 15-25 mg / mL; in step 2), when the protein is dissolved in the alkaline aqueous solution, the alkaline aqueous solution is a sodium hydroxide solution, and the protein solution concentration is 4-6 mg / mL; in step 3), the first organic solvent is ethanol, and the fatty acid solution concentration is 25-35 mmol / L; in step 4), the second organic solvent is a mixture of dichloromethane and ethanol, with a volume ratio of dichloromethane to ethanol of 1:
1.
8. The method for preparing the shellac-based composite nanodelivery system as described in claim 6, characterized in that, In step 5), hydrochloric acid is used to adjust the pH to 10-12; for neutral or weakly acidic pH values of 4-7, hydrochloric acid is used to adjust the pH to 4-7.
9. The method for preparing the shellac-based composite nanodelivery system as described in claim 6, characterized in that, In step 5), the stirring time is 3-10 minutes and the standing time is 3-10 minutes.
10. The use of the shellac-based composite nanodelivery system as described in any one of claims 1-5 in the preparation of food, health products or aquatic feed additives.
Citation Information
Patent Citations
Preparation method of origanum vulgare essential oil loaded shellac-sodium caseinate composite nanoparticles
CN121154581A
